This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03950/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB03950/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03950/identifier/pubchem-compound/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03950/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03950/identifier/drugbank/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03950
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03950 n14:DB03950
dcterms:title
(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide
adms:identifier
n9:393679 n10:446277 n11:46505986 n12:DB03950 n13:SBS
n3:IUPAC-Name
n4:271B52CD-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B52D3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B52D2-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B52CF-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B52D0-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B52D1-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B52CB-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B52CC-363D-11E5-9242-09173F13E4C5 n4:271B52C9-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B52CA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B52D9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B52DA-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B52D4-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B52D5-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B52D7-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B52D6-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B52D8-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B52DF-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B52E1-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B52E2-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B52DE-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B52DD-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B52E0-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B52CE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B52DB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B52DC-363D-11E5-9242-09173F13E4C5